W. L. Gore & Associates Launches GORE<sup>&reg;</sup> SYNECOR Intraperitoneal Biomaterial in Europe, the Middle East and South Africa

Patient complexity is on the rise1 and surgeons need a high-quality material for hernia repair in complex patients (VHWG 2).2

Feb 22, 2021

W. L. GORE & ASSOCIATES ANNOUNCES ENCOURAGING SIX-MONTH RESULTS WITH ITS NOVEL BIOSYNTHETIC TISSUE VALVE

At the American Heart Association Virtual Scientific Sessions 2020.

Nov 18, 2020

W. L. GORE & ASSOCIATES CELEBRATES THE 50TH ANNIVERSARY OF ePTFE DISCOVERY

Expanded Polytetrafluoroethylene (ePTFE) Serves as a Core Material for Many Gore Innovations

Oct 8, 2019

Gore Receives CE Mark for the GORE® CARDIOFORM ASD Occluder for the Treatment of Atrial Septal Defects in Europe

CE Mark supported by data from the Gore ASSURED Clinical Study, demonstrating 100 percent closure success

Oct 2, 2019

Gore to Highlight Real-World Aortic Data at 45th Annual VEITHsymposium<sup>&reg;</sup>

Company shares findings from the Global Registry for Endovascular Aortic Treatment (GREAT), the largest industry-sponsored registry of aortic stent grafts

Nov 6, 2018

First Patient in Europe Receives Implant of GORE® EXCLUDER® Conformable AAA Endoprosthesis with ACTIVE CONTROL System and Enrolls in Post-Market Registry

Investigator initiated EXCeL Registry will assess safety and abdominal aortic aneurysm treatment success in patients with challenging anatomies

Sep 12, 2018

Gore Acquires Pipeline Medical Technologies, Inc.

Acquisition of transcatheter mitral chordal repair technology builds on Gore’s structural heart capabilities

Sep 6, 2018